The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective
Abstract
Epithelial–mesenchymal transition (EMT) is a key step in transdifferentiation process in solid cancer development. Forthcoming evidence suggest that the stratified program transforms polarized, immotile epithelial cells to migratory mesenchymal cells associated with enhancement of breast cancer stemness, metastasis, and drug resistance. It involves primarily several signaling pathways, such as transforming growth factor‐β (TGF‐β), cadherin, notch, plasminogen activator protein inhibitor, urokinase plasminogen activator, and WNT/beta catenin pathways. However, current understanding on the crosstalk of multisignaling pathways and assemblies of key transcription factors remain to be explored. In this review, we focus on the crosstalk of signal transduction pathways linked to the current therapeutic and drug development strategies. We have also performed the computational modeling on indepth the structure and conformational dynamic studies of regulatory proteins and analyze molecular interactions with their associate factors to understand the complicated process of EMT in breast cancer progression and metastasis. Electrostatic potential surfaces have been analyzed that help in optimization of electrostatic interactions between the protein and its ligand. Therefore, understanding the biological implications underlying the EMT process through molecular biology with biocomputation and structural biology approaches will enable the development of new therapeutic strategies to sensitize tumors to conventional therapy and suppress their metastatic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
van Grunsven, L. A., Taelman, V. F., Michiels, C., Verstappen, G., Souopgui, J., Nichane, M., Moens, E., Opdecamp, K., Vanhomwegen, J., Kricha, S., et al. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.02.045 · Cited by 57
The Role of MicroRNA-200 in Progression of Human Colorectal and Breast Cancer
Bojmar, L., Karlsson, E. A., Ellegård, S., Olsson, H., Björnsson, B., Hallböök, O. J., Larsson, M., Stål, O., & Sandström, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084815 · Cited by 51
Elzamly, S., Badri, N., Padilla, O., Dwivedi, A. K., Alvarado, L. A., Hamilton, M., Diab, N., Rock, C. D., Elfar, A., Teleb, M., et al. (2018) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223418788074 · Cited by 49
Ibarrola, N., Kratchmarova, I., Nakajima, D., Schiemann, W. P., Moustakas, A., Pandey, A., & Mann, M. (2004) · BMC Cell Biology · doi:10.1186/1471-2121-5-2 · Cited by 42
Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review)
ZHU, N., Li, Q., Luo, Z., et al. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1676 · Cited by 40
Ma, L., Wang, D. D., Huang, Y., Yan, H., Wong, M. P., & Lee, V. H.-F. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0522-3 · Cited by 39
Tuhkanen, H. E., Soini, Y., Kosma, V., Anttila, M., Sironen, R. K., Hämäläinen, K. M., Kukkonen, L., Virtanen, I., & Mannermaa, A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-289 · Cited by 33
Single versus combination immunotherapy drug treatment in melanoma
Grimaldi, A. M., Marincola, F. M., & Ascierto, P. A. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1128891 · Cited by 21
Wang, X., He, X., Zhao, F., Wang, J., Zhang, H., Shi, F., Zhang, Y., Cai, K., & Dou, J. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-68 · Cited by 19
Sakanaka, M., Tanaka, S., Sugimoto, Y., & Ichikawa, A. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00218.2008 · Cited by 16
Endocrine therapy for advanced breast cancer.
Shah, P. D., & Dickler, M. N. (2014) · PubMed · Cited by 15
Notch signaling in hepatocellular carcinoma: molecular targeting in an advanced disease
Kunnimalaiyaan, M., Balamurugan, M., Gamblin, T. C., Kunnimalaiyaan, S., & Sokolowski, K. M. (2015) · Hepatoma Research · doi:10.4103/2394-5079.154132 · Cited by 11
The asymmetric division and tumorigenesis of stem cells
Qizhao, W., Lü, Y., Jiang, N., Diao, Y., & Xu, R. (2010) · 癌症:英文版 · doi:10.5732/cjc.009.10668 · Cited by 8
Cited by
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
Gough, P., & Myles, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585880 · Cited by 268
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
Huang, Z., Chu, L., Liang, J., Tan, X., Wang, Y., Wen, J., Chen, J., Wu, Y., Liu, S., Liao, J., et al. (2021) · Hepatology · doi:10.1002/hep.31673 · Cited by 82
Metabolic Rewiring and Redox Alterations in Malignant Pleural Mesothelioma
Urso, L., Cavallari, I., Sharova, E., Ciccarese, F., Pasello, G., & Ciminale, V. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0661-9 · Cited by 47
Metadata
- Authors
- Das, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S., & Pal, M.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-02-05
- Volume
- 234
- Issue
- 9
- Pages
- 14535-14555
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2911725508
- Cited by
- 263
- References
- 213
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.